Hoya introduces Sensity, light reactive lenses

Article

Hoya recently introduced its new photochromic lenses, Hoya Sensity featuring Stabilight Technology, which the company says helps the lenses perform consistently in different climates and seasons.

Uithoorn, Netherlands-Hoya recently introduced its new photochromic lenses, Hoya Sensity featuring Stabilight Technology, which the company says helps the lenses perform consistently in different climates and seasons.

Hoya says the Hoya Sensity lens darkens up to 45 percent in 90 seconds, but the lens also fade back to full clarity quickly, lightening up to 23 percent after one minute, all while maintaining UV protection.

The company says the lenses are made using its Photochromic Precision Technology, a “microscopically accurate spin coating process tailored to freeform lens production” which ensures an even distribution of molecules over the entire lens surface.

Hoya Sensity can be supplied in all Hoya single vision, bifocal, and progressive lens designs. It can also be combined with Hoya premium coatings and comes in several stock options. The lenses are available in Bronze Brown and Silver Grey. 

Next: Adlens presents Adlens Sundials

DrFirst, My Vision Express partner to deliver comprehensive e-Rx to ECPs

Avellino launches DNA test for LASIK safety

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.